The VA intends to issue an RFP for a contract to supply Buprenorphine/Naloxone tablets to the VA, DOD, Bureau of Prisons, and Indian Health Service. The contract will be for one base year plus four one-year option periods. The estimated annual requirements are 171,239 bottles of the 2mg/0.5mg tablets and 251,144 bottles of the 8mg/2mg tablets. The items will be distributed through the VA's and DOD's Pharmaceutical Prime Vendor Programs. Offerors must supply the exact drug name and a unique NDC number, and glass bottles are not acceptable.